Disease Zoetis statement on CVMP opinion relative to Suvaxyn PRRS MLV No product-specific concern identified for Suvaxyn PRRS MLV and benefit/risk balance for the product remains favourable. 23 June 2020 2 minute read By: Zoetis Europe Sponsored Article Zoetis Our Partners Lallemand Lanxess Hamlet Protein Thermo Fisher Scientific Axcentive Zoetis More from this author More News View all US hog futures jump 2% - CME Market Trends Markets and economics 22 April 2024 2 minute read US pork exports to Central America remain strong - USMEF Market Trends Markets and economics 19 April 2024 1 minute read Shipments up 17% so far this year Brazil pork exports perform well in March - Cepea Market Trends Markets and economics 19 April 2024 1 minute read Brazil shipped 90.7 thousand tons of pork in March Sponsored Article Zoetis Our Partners Lallemand Lanxess Hamlet Protein Thermo Fisher Scientific Axcentive
23 June 2020
2 minute read
By: 
